Australia makes COVID-19 vaccine supply agreements with Novavax and Pfizer
The Australian Government has inked an agreement with Novavax for 40 million COVID-19 vaccine doses; and with Pfizer/BioNTech for 10 million doses.
Archives for November 5, 2020
Merck to acquire VelosBio, strengthening oncology pipeline with investigational antibody-drug conjugate
Merck (MSD outside the US and Canada) will acquire San Diego’s VelosBio in a $2.75bn deal.
Chinese cell therapy player generates $300m in IPO
China based CAR-T biotech, JW Therapeutics, has raised $300m in its IPO on the Hong Kong Stock Exchange.
Only ‘small chance’ of distributing the AZD1222 vaccine in the UK before Christmas
Late-stage trial results on AstraZeneca’s COVID-19 vaccine could be ready by December.